Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) targeting central nervous system disorders. Its structure supports the creation of more complex molecules with potential antipsychotic, anxiolytic, or antidepressant activity. Commonly utilized in research settings for medicinal chemistry projects aiming at novel piperazine-based therapeutics. Also serves as a building block in the preparation of receptor ligands, especially for serotonin and dopamine receptors.